Tuning Macrophage Phenotype to Mitigate Skeletal Muscle Fibrosis

David M Stepien,Charles Hwang,Simone Marini,Chase A Pagani,Michael Sorkin,Noelle D Visser,Amanda K Huber,Nicole J Edwards,Shawn J Loder,Kaetlin Vasquez,Carlos A Aguilar,Ravi Kumar,Shamik Mascharak,Michael T Longaker,Jun Li,Benjamin Levi
DOI: https://doi.org/10.4049/jimmunol.1900814
2020-04-15
Abstract:Myeloid cells are critical to the development of fibrosis following muscle injury; however, the mechanism of their role in fibrosis formation remains unclear. In this study, we demonstrate that myeloid cell-derived TGF-β1 signaling is increased in a profibrotic ischemia reperfusion and cardiotoxin muscle injury model. We found that myeloid-specific deletion of Tgfb1 abrogates the fibrotic response in this injury model and reduces fibro/adipogenic progenitor cell proliferation while simultaneously enhancing muscle regeneration, which is abrogated by adaptive transfer of normal macrophages. Similarly, a murine TGFBRII-Fc ligand trap administered after injury significantly reduced muscle fibrosis and improved muscle regeneration. This study ultimately demonstrates that infiltrating myeloid cell TGF-β1 is responsible for the development of traumatic muscle fibrosis, and its blockade offers a promising therapeutic target for preventing muscle fibrosis after ischemic injury.
What problem does this paper attempt to address?